Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	2	4	50	160	280	390
Market Cap Growth	-10.29%	-92.06%	-68.90%	-42.99%	-28.09%	878.53%
Enterprise Value	3	-2	21	147	273	341
PE Ratio	-	-0.11	-0.74	-4.62	-5.51	-8.26
PB Ratio	-0.66	-0.37	2.22	15.61	7.74	9.08
P/FCF Ratio	-0.73	-0.12	-1.42	-5.67	-7.10	-12.33
P/OCF Ratio	-0.73	-0.12	-1.42	-5.67	-7.11	-12.42
EV/EBITDA Ratio	-0.77	0.06	-0.32	-5.15	-5.59	-7.39
EV/EBIT Ratio	-0.74	0.06	-0.32	-5.05	-5.53	-7.35
EV/FCF Ratio	-0.79	0.06	-0.59	-5.22	-6.93	-10.79
Debt / Equity Ratio	-0.29	-1.26	0.60	1.18	0.44	0
Debt / EBITDA Ratio	-0.31	-0.40	-0.21	-0.42	-0.32	-
Debt / FCF Ratio	-0.32	-0.42	-0.38	-0.43	-0.40	-
Quick Ratio	0.20	0.83	4.25	2.51	4.77	6.23
Current Ratio	0.24	0.87	4.37	2.63	4.89	6.45
Interest Coverage	-15.48	-17.66	-52.44	-23.74	-31.28	-6795.00
Return on Equity (ROE)	102.16%	338.32%	-298.10%	-338.00%	-140.49%	-109.96%
Return on Assets (ROA)	-338.99%	-170.74%	-147.83%	-130.59%	-86.30%	-93.03%
Return on Capital (ROIC)	134.98%	-1263.55%	-184.20%	-150.24%	-97.27%	-110.85%
Earnings Yield	-892.59%	-914.73%	-134.33%	-21.65%	-18.16%	-12.11%
FCF Yield	-784.03%	-809.37%	-70.64%	-17.64%	-14.08%	-8.11%
Buyback Yield / Dilution	-26.83%	-23.85%	-74.36%	-5.42%	-17.35%	-551.81%
Total Shareholder Return	-26.83%	-23.85%	-74.36%	-5.42%	-17.35%	-551.81%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.